ストックスクリーナーアプリを入手
140.83
5.62%
-8.39
アフターアワーズ：
140.88
0.05
+0.04%
前日終値:
$149.22
開ける：
$149
24時間の取引高:
2.25M
Relative Volume:
2.12
時価総額：
$9.41B
収益：
$12.82B
当期純損益:
$936.34M
株価収益率:
13.11
EPS:
10.74
ネットキャッシュフロー:
$1.47B
1週間 パフォーマンス:
+28.80%
1か月 パフォーマンス:
+22.76%
6か月 パフォーマンス:
+10.19%
1年 パフォーマンス:
-18.16%
1日の値動き範囲:
$139.54
$151.42
1週間の範囲:
$108.88
$151.42
52週間の値動き範囲:
$101.00
$178.38
Davita Inc Stock (DVA) Company Profile
Compare DVA vs HCA, THC, FMS, UHS, ENSG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DVA
Davita Inc
|
140.83 | 9.98B | 12.82B | 936.34M | 1.47B | 10.74 |
|
HCA
Hca Healthcare Inc
|
501.69 | 117.24B | 75.60B | 7.78B | 7.69B | 28.38 |
|
THC
Tenet Healthcare Corp
|
201.37 | 17.22B | 20.69B | 2.40B | 1.55B | 15.62 |
|
FMS
Fresenius Medical Care Ag Adr
|
24.08 | 14.12B | 21.23B | 924.30M | 2.22B | 1.2272 |
|
UHS
Universal Health Services Inc
|
218.56 | 13.53B | 16.08B | 1.20B | 1.06B | 17.82 |
|
ENSG
Ensign Group Inc
|
197.80 | 11.46B | 4.11B | 239.98M | 193.10M | 4.12 |
Davita Inc Stock (DVA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-03-06 | 開始されました | Barclays | Equal Weight |
| 2023-08-07 | アップグレード | UBS | Neutral → Buy |
| 2022-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-31 | ダウングレード | UBS | Buy → Neutral |
| 2022-08-19 | 再開されました | UBS | Buy |
| 2022-06-21 | 繰り返されました | BofA Securities | Underperform |
| 2021-09-10 | 開始されました | Cowen | Market Perform |
| 2021-08-12 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2021-03-26 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2021-01-05 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-01-24 | アップグレード | Goldman | Neutral → Buy |
| 2019-11-07 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2019-10-25 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2019-09-11 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2019-01-08 | アップグレード | UBS | Sell → Neutral |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2018-12-14 | 開始されました | Barclays | Overweight |
| 2018-11-28 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-11-16 | 開始されました | UBS | Sell |
| 2018-11-08 | ダウングレード | Raymond James | Strong Buy → Mkt Perform |
| 2018-09-13 | アップグレード | JP Morgan | Underweight → Neutral |
| 2018-01-04 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2017-12-12 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2017-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2017-12-07 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2017-11-08 | 繰り返されました | RBC Capital Mkts | Sector Perform |
| 2017-10-09 | ダウングレード | JP Morgan | Neutral → Underweight |
| 2017-06-26 | ダウングレード | Jefferies | Buy → Hold |
| 2016-12-13 | ダウングレード | Robert W. Baird | Outperform → Neutral |
すべてを表示
Davita Inc (DVA) 最新ニュース
Even With A 30% Surge, Cautious Investors Are Not Rewarding DaVita Inc.'s (NYSE:DVA) Performance Completely - simplywall.st
Warren Buffett's Successor Greg Abel Just Sold This Long-Time Berkshire Hathaway Holding - The Motley Fool
DaVita, Elara deal could signal new take on kidney, home care - Modern Healthcare News
Should Value Investors Buy DaVita (DVA) Stock? - Yahoo Finance
Why DaVita HealthCare (DVA) is a Top Value Stock for the Long-Term - Yahoo Finance
DaVita Links IKC Profitability With Elara Home Care To Recast Growth - Yahoo Finance
DaVita stock price pops again as 2026 outlook fuels fresh Wall Street targets - TechStock²
UBS Raises Price Target for DaVita (DVA) to $190, Maintains Buy Rating | DVA Stock News - GuruFocus
DaVita Projects Significant EPS Growth Amid Strategic Expansion - StocksToTrade
DaVita stock price target raised to $190 from $186 at UBS on growth outlook - Investing.com Australia
Why Is DaVita (DVA) Stock Rocketing Higher Today - The Globe and Mail
DVA Q4 Deep Dive: Clinical Initiatives and Integrated Care Drive Outlook Amid Margin Compression - The Globe and Mail
Dallas Team Featured as Litigator of the Week - Winston & Strawn
Research Alert: CFRA Maintains Hold View On Shares Of Davita Inc. - 富途牛牛
Is DaVita stock underperforming the Dow? - MSN
DaVita Home Care Partnership Puts Valuation And Risk Profile In Focus - Sahm
DaVita’s Q4 Earnings Triumph Sparks Market Interest - timothysykes.com
DaVita Inc. stock outperforms competitors on strong trading day - MarketWatch
DaVita (DVA) Shares Surge on Strong Q4 Results and Optimistic 20 - GuruFocus
DaVita Stock Surges as Q4 Earnings Exceed Expectations - StocksToTrade
DaVita Celebrates Strong Earnings as Strategic Investments Boost Future Outlook - timothysykes.com
Ares, DaVita Make Strategic Investment in Elara Caring - Hospice News
DaVita climbs as Q4 beat outshines Berkshire Hathaway insider sale - Seeking Alpha
Explore DaVita Within Dow Jones Industrial Average Healthcare Space - Kalkine Media
DaVita (DVA) Shares Surge Over 21% Amid Market Moves - GuruFocus
DaVita stock price jumps nearly 20% as 2026 profit outlook beats Street; what investors watch next - TechStock²
What Sent DaVita Stock Soaring On Tuesday? - Finviz
DaVita Inc Stock Soars 25% After DaVita Beats Q4 Results And Raises 2026 Outlook - Nasdaq
DaVita Stock Rallies On Profit Beat, Confident 2026 View - Benzinga
DaVita Stock Soars as Q4 Earnings and Strategy Surpass Expectations - StocksToTrade
Silver Surges Over 15%; Pfizer Earnings Top Views - Benzinga
Short Interest in DaVita Inc. (NYSE:DVA) Decreases By 14.2% - MarketBeat
DaVita’s Remarkable Financial Surge Surpasses Analysts’ Expectations - timothysykes.com
TD Cowen reiterates Hold rating on DaVita stock with $133 price target - Investing.com
DaVita (DVA) Soars Over 23% Amid Positive Market Movement - GuruFocus
DaVita: Some Success Is Possible, But Volatility Is Still Heavy (NYSE:DVA) - Seeking Alpha
DaVita Stock Up Following Q4 Earnings & Revenue Beat, Margins Expand - TradingView
DaVita (NYSE:DVA) Shares Gap Up After Earnings Beat - MarketBeat
Davita Posts Upbeat Q4 Earnings, Joins Woodward, Terawulf And Other Big Stocks Moving Higher On Tuesday - Benzinga
Barclays Raises Price Target for DaVita (DVA) to $158 | DVA Stoc - GuruFocus
DaVita Q4 Revenue Up 10%; Announces Strategic Investment In Elara Caring - Nasdaq
DaVita Inc. (NYSE:DVA) Q4 2025 Earnings Call Transcript - Insider Monkey
DaVita rises on upbeat annual profit forecast - TradingView
Barclays Adjusts Price Target on DaVita to $158 From $143 - marketscreener.com
Is DaVita (DVA) Offering Value After A 37% One-Year Share Price Decline? - Yahoo Finance
Mirae Asset Global Investments Co. Ltd. Buys 11,718 Shares of DaVita Inc. $DVA - MarketBeat
DaVita Stock Pre-Market (+14%): Stellar Q4 Earnings and Aggressive 2026 Guidance - Trefis
DaVita Inc (DVA) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges - GuruFocus
DaVita Inc (DVA) Q4 2025 Earnings Call Highlights: Strong Financial Performance Amid Challenges By GuruFocus - Investing.com Canada
Why Did DaVita Stock Jump 15% After Hours Today? - Asianet Newsable
DaVita Q4 2025 Results: Revenue Beat, Profit Growth, and 2026 OutlookNews and Statistics - IndexBox
Davita Inc (DVA) 財務データ
収益
当期純利益
現金流量
EPS
5.86%
1.25%
大文字化:
|
ボリューム (24 時間):